GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Allergan Plc (AGN) [hlAlert]

Watson Pharmaceuticals, Inc. (Watson) is a specialty pharmaceutical company engaged in the development, manufacture, marketing, sale and distribution of brand and generic (off-patent) pharmaceutical products. Watson operates and manages its business as three operating segments: Generic, Brand and Distribution. As of December 31, 2008,
the Company marketed approximately 150 generic pharmaceutical product families and 27 brand pharmaceutical product families through its generic and brand divisions, respectively, and distributed approximately 8,000 stock-keeping units (SKUs) through its distribution division. The Company?s operations are based predominantly in the United States and India, with its key commercial market being the United States. In July 2008, Watson and Mylan Inc. announced that Mylan Inc. has acquired Watson?s 50% interest in the Somerset Pharmaceuticals, Inc. joint venture. In December 2009, the Company completed the acquisition of Arrow Group.
.
( Total: 28 Current Stock Recommendations )
Allergan Plc   (28)
Hold 29% Buy 71%
Related companies
Sanofi-aventis Sa   (17)
Hold 47% Buy 53%
Novo Nordisk A/s   (18)
Sell 17% Hold 44% Buy 39%
Amgen Inc.   (30)
Hold 47% Buy 53%
Gilead Sciences, ...   (48)
Sell Hold 15% Buy 81%
Teva Pharmaceutical ...   (41)
Hold 27% Buy 73%
Celgene Corporation   (44)
Sell Hold Buy 84%
Allergan Plc   (28)
Hold 29% Buy 71%
Biogen Idec Inc   (41)
Sell Hold 27% Buy 68%
Filter by Gains:   
  
Rating:
Buy AGN
up 7.12 %
Allergan Plc (AGN) rated Buy with price target $354 by Mizuho
Tuesday,  Nov 24, 2015  1:25 PM ET

Rating:
Buy AGN
up 21.42 %
Allergan Plc (AGN) rated Buy by Nomura
Tuesday,  Sep 29, 2015  10:25 AM ET

Rating:
Buy AGN
up 13.11 %

Rating:
Buy AGN
down 6.10 %

Rating:
Buy AGN
down 0.88 %

Rating:
Buy AGN
up 4.93 %

Rating:
Buy AGN
up 7.12 %
Actavis Inc. (ACT) rated Buy with price target $358 by Mizuho
Friday,  May 8, 2015  8:25 AM ET

Rating:
Buy AGN
up 13.11 %

Rating:
Buy AGN
up 616.58 %
Actavis Inc. (ACT) rated Buy with price target $340 by Argus
Friday,  Feb 20, 2015  8:25 AM ET

Rating:
Buy AGN
up 198.07 %

Rating:
Buy AGN
up 10.69 %

Rating:
Buy AGN
up 13.11 %

Rating:
Buy AGN
up 135.09 %

Rating:
Buy AGN
up 616.58 %
Actavis Inc. (ACT) rated Buy with price target $310 by Argus
Friday,  Nov 21, 2014  9:25 AM ET

Rating:
Buy AGN
up 509.13 %
Actavis Inc. (ACT) rated Buy with price target $333 by UBS
Tuesday,  Nov 18, 2014  1:25 PM ET

Your Recent Stocks
SymbolLastChange
AGN 227.17 down  -27.18 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy